Sphera Funds Amends Jasper Therapeutics Stake, Part of Group Holding
Ticker: JSPRW · Form: SC 13G/A · Filed: Feb 5, 2024 · CIK: 1788028
| Field | Detail |
|---|---|
| Company | Jasper Therapeutics, Inc. (JSPRW) |
| Form Type | SC 13G/A |
| Filed Date | Feb 5, 2024 |
| Risk Level | low |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, biotech, investor-update
TL;DR
**Sphera Funds Management updated its Jasper Therapeutics stake, showing group ownership.**
AI Summary
Sphera Funds Management Ltd. filed an amended SC 13G/A on February 5, 2024, indicating a change in their ownership of Jasper Therapeutics, Inc. voting common stock as of December 31, 2023. This amendment, filed under Rule 13d-1(c), shows that Sphera is part of a group, Sphera Global Healthcare GP Ltd and Sphera Global Healthcare Management LP, that collectively holds a significant stake. This matters to investors because large institutional holdings can influence stock stability and future strategic decisions, signaling confidence or potential shifts in a company's direction.
Why It Matters
This filing reveals an institutional investor's updated position, which can signal confidence or a change in sentiment, potentially influencing other investors' perceptions of Jasper Therapeutics.
Risk Assessment
Risk Level: low — This filing is a routine update on institutional ownership and does not inherently introduce new risks to the company or its investors.
Analyst Insight
Investors should note the continued institutional interest from Sphera Funds Management Ltd. and its affiliated group. While this filing doesn't disclose specific share counts or percentages, it confirms their ongoing involvement. Smart investors might monitor future filings for changes in their stake, as significant increases or decreases could signal a shift in their outlook on Jasper Therapeutics.
Key Players & Entities
- Sphera Funds Management Ltd. (company) — the reporting person filing the SC 13G/A
- Jasper Therapeutics, Inc. (company) — the subject company whose securities are being reported
- Sphera Global Healthcare GP Ltd (company) — a member of the group with shared voting power
- Sphera Global Healthcare Management LP (company) — a member of the group with shared voting power
- December 31, 2023 (date) — the date of the event requiring the filing
FAQ
What type of securities of Jasper Therapeutics, Inc. are covered by this filing?
This filing covers the Voting Common Stock, par value $0.0001 per share, of Jasper Therapeutics, Inc., as stated in the 'Title of Class of Securities' section.
Who is the reporting person for this SC 13G/A amendment?
The reporting person is Sphera Funds Management Ltd., as identified in 'NAME OF REPORTING PERSONS' on page 2 of the filing.
What is the CUSIP number for Jasper Therapeutics, Inc. securities mentioned in this filing?
The CUSIP number is 471871103, as listed on the cover page and page 2 of the filing.
Under which rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13d-1(c), indicated by the checked box on the first page of the filing.
What is the place of organization for Sphera Funds Management Ltd.?
The place of organization for Sphera Funds Management Ltd. is Israel, as stated in 'CITIZENSHIP OR PLACE OF ORGANIZATION' on page 2 of the filing.
Filing Stats: 1,528 words · 6 min read · ~5 pages · Grade level 12.4 · Accepted 2024-02-05 09:15:02
Key Financial Figures
- $0.0001 — Issuer) Voting Common Stock, par value $0.0001 per share (Title of Class of Securiti
Filing Documents
- zk2430880.htm (SC 13G/A) — 85KB
- 0001178913-24-000365.txt ( ) — 87KB
(a)
Item 1. (a) Name of Issuer : Jasper Therapeutics, Inc. (b) Address of Issuer's Principal Executive Offices : 2200 Bridge Pkwy, Suite #102, Redwood City, CA 94065
(a)
Item 2. (a) Name of Person Filing : Sphera Funds Management Ltd. Sphera Global Healthcare GP Ltd. Sphera Global Healthcare Management LP (b) Address of Principal Business Office : Sphera Funds Management Ltd. – 4 Itzak Sade, Building A, 29 th Floor, Tel Aviv 6777504, Israel Sphera Global Healthcare GP Ltd. – 4 Itzak Sade, Building A, 29 th Floor, Tel Aviv 6777504, Israel Sphera Global Healthcare Management LP – 4 Itzak Sade, Building A, 29 th Floor, Tel Aviv 6777504, Israel (c) Citizenship : Sphera Funds Management Ltd. – Israel Sphera Global Healthcare GP Ltd. – Israel Sphera Global Healthcare Management LP – Israel (d) Title of Class of Securities : Voting Common Stock, par value $0.0001 per share (e) CUSIP Number : 471871103 Item 3 . Not applicable. 5 Item 4 . (a) Amount beneficially owned : See row 9 of cover page of each reporting person. The securities reported herein by Sphera Funds Management Ltd., Sphera Global Healthcare GP Ltd. and Sphera Global Healthcare Management LP are beneficially owned as follows: 1,090,382 Common Shares representing a total of 0.98% of the total Common Shares outstanding are held directly by Sphera Global Healthcare Master Fund, which has delegated its investment management authority to Sphera Global Healthcare Management LP (the " Management Company "). 6,040,243 Common Shares representing a total of 5.41% of the total Common Shares outstanding, are held directly by Sphera Biotech Master Fund, L.P., which has delegated its investment management authority to the Management Company. The Management Company is managed, controlled, and operated by its general partner, Sphera Global Healthcare GP Ltd., the shares of which are owned 90% by Sphera Funds Management Ltd. This Statement shall not be construed as an admission by any of the Reporting Persons that it is the beneficial owner of any of the securities covered by this Statement, and each Reporting Person disclaims benefi